HIF2α Negatively Regulates MYCN Protein Levels and Promotes a Low-Risk Noradrenergic Phenotype in Neuroblastoma

Investigators showed that induced expression of HIF2α in MYCN-amplified neuroblastoma substantially reduces MYCN protein levels and attenuates proliferation while it induces several features of noradrenergic differentiation and impedes xenograft tumor growth.